Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gogoro Inc (GGR) vs Eli Lilly And Co (LLY) Price & Performance

Gogoro IncTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

Gogoro Inc vs Eli Lilly And Co — how do they compare? Gogoro Inc trades at $3.86 (market cap $77.38M), while Eli Lilly And Co trades at $1,180.1 (market cap $1.03T). The key difference: Eli Lilly And Co is far larger — about 13310.9× Gogoro Inc's market cap, and Eli Lilly And Co pays a 0.6% dividend while Gogoro Inc pays none. Which is the better fit depends on your goals.

GGRLLY
Market Cap
$77.38M$1.03T
Sector
TechnologyHealth
52-Week High
$7.89$1.24K
52-Week Low
$2.74$625.65
Enterprise Value
$379.83M$1.07T
Dividend Yield
0.6%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gogoro Inc

No Aura AI signal available yet.

Eli Lilly And Co

LLY trades at $1,154.27, down 2.6% today, amid a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q1 2026 EPS of $8.55 surpassing the $6.97 forecast. Revenue surged to $65.18B in 2025, driving a net income margin of 34.99%. Recent news includes the acquisition of AtaiBeckley for $2.8 billion, expanding its neuroscience pipeline.

Outlook remains positive with a consensus price target of $1,380, though high valuation multiples (P/E 41.09) and competitive pressures in obesity drugs present risks. Analyst sentiment is strongly bullish (73% buy ratings), supporting further upside if execution continues.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Gogoro Inc

Gogoro is a global technology leader in battery-swapping ecosystems for electric two-wheelers. It provides smart, sustainable urban mobility solutions and manages an extensive network of battery stations.

Read more on GGR

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY